The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 13,649 | 857,338 | SH | SOLE | 857,338 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 4,570 | 290,189 | SH | SOLE | 290,189 | 0 | 0 | ||
ALLAKOS INC | COM | 01671P100 | 40,349 | 4,792,000 | SH | SOLE | 4,792,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 21,945 | 2,985,757 | SH | SOLE | 2,985,757 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 27,882 | 899,700 | SH | SOLE | 899,700 | 0 | 0 | ||
APTINYX INC | COM | 03836N103 | 537 | 1,883,244 | SH | SOLE | 1,883,244 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 9,761 | 285,331 | SH | SOLE | 285,331 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 7,119 | 3,746,857 | SH | SOLE | 3,746,857 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 11,095 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
Arcutis Biotherapeutics | COM | 03969K108 | 128,527 | 8,684,232 | SH | SOLE | 8,684,232 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 9,970 | 1,440,757 | SH | SOLE | 1,440,757 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 12,395 | 393,000 | SH | SOLE | 393,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 113,854 | 4,345,559 | SH | SOLE | 4,345,559 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 24,382 | 2,109,154 | SH | SOLE | 2,109,154 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 25,891 | 1,414,823 | SH | SOLE | 1,414,823 | 0 | 0 | ||
ESSA Pharma, Inc. | COM NEW | 29668H708 | 1,525 | 605,141 | SH | SOLE | 605,141 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 17,810 | 5,162,348 | SH | SOLE | 5,162,348 | 0 | 0 | ||
HILLEVAX INC | COM | 43157M102 | 163,257 | 9,758,359 | SH | SOLE | 9,758,359 | 0 | 0 | ||
IMAGO BIOSCIENCES INC | COM | 45250K107 | 143,340 | 3,987,207 | SH | SOLE | 3,987,207 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 7,107 | 203,684 | SH | SOLE | 203,684 | 0 | 0 | ||
Immunovant, Inc. | COM | 45258J102 | 10,397 | 585,759 | SH | SOLE | 585,759 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 21,895 | 3,238,859 | SH | SOLE | 3,238,859 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 79,199 | 999,737 | SH | SOLE | 999,737 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 11,548 | 746,479 | SH | SOLE | 746,479 | 0 | 0 | ||
Mirum Pharmaceuticals, Inc. | COM | 604749101 | 75,272 | 3,860,107 | SH | SOLE | 3,860,107 | 0 | 0 | ||
NABRIVA THERAPEUTICS PLC | SHS NEW 2022 | G63637139 | 32 | 17,025 | SH | SOLE | 17,025 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 101,823 | 9,341,551 | SH | SOLE | 9,341,551 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 434 | 500,333 | SH | SOLE | 500,333 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 7,706 | 127,900 | SH | SOLE | 127,900 | 0 | 0 | ||
Passage Bio, Inc. | COM | 702712100 | 5,185 | 3,756,915 | SH | SOLE | 3,756,915 | 0 | 0 | ||
Phathom Pharmaceuticals, Inc. | COM | 71722W107 | 94,328 | 8,407,152 | SH | SOLE | 8,407,152 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 25,338 | 931,560 | SH | SOLE | 931,560 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 55,153 | 1,894,000 | SH | SOLE | 1,894,000 | 0 | 0 | ||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 13,438 | 881,173 | SH | SOLE | 881,173 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 14,354 | 1,776,479 | SH | SOLE | 1,776,479 | 0 | 0 | ||
Syndax Pharmaceuticals, Inc. | COM | 87164F105 | 94,390 | 3,708,838 | SH | SOLE | 3,708,838 | 0 | 0 | ||
THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 6,963 | 1,398,194 | SH | SOLE | 1,398,194 | 0 | 0 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | 12,861 | 6,663,590 | SH | SOLE | 6,663,590 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 10,090 | 1,327,665 | SH | SOLE | 1,327,665 | 0 | 0 | ||
Tarsus Pharmaceuticals, Inc. | COM | 87650L103 | 26,205 | 1,787,527 | SH | SOLE | 1,787,527 | 0 | 0 | ||
VECTIVBIO HLDG AG | ORD SHS | H9060V101 | 11,481 | 1,333,400 | SH | SOLE | 1,333,400 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 73,575 | 2,815,720 | SH | SOLE | 2,815,720 | 0 | 0 | ||
Vaxcyte, Inc. | COM | 92243G108 | 67,006 | 1,397,405 | SH | SOLE | 1,397,405 | 0 | 0 | ||
ZYMEWORKS DEL INC | COM | 98985Y108 | 4,795 | 610,000 | SH | SOLE | 610,000 | 0 | 0 |